VivoSim Labs, Inc.
VivoSim Labs, Inc. (VIVS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VIVS · as of Jun 8, 2026
Key Statistics
Explore VivoSim Labs, Inc. Data
vivs stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
vivs competitorsVIVS
CYCN
IBO
KTTA
NBY
PLRZStock Performance
Full HistoryAbout VivoSim Labs, Inc.
VivoSim Labs, Inc. is a biotechnology company dedicated to developing sophisticated 3D tissue models designed to replicate key aspects of human diseases. At the heart of their operations is a propriet…
what is vivosim labs, inc. · vivs stock overview · vivosim labs, inc. company profile · who is vivosim labs, inc. ceo · vivs NASDAQ · vivosim labs, inc. headquarters · vivosim labs, inc. business segments
About Stock Overview & Key Data
VivoSim Labs, Inc. (VIVS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 14, 2012. As of the latest trading session, VIVS stock price is $1.19, with a market capitalization of $3.1M. The stock has returned -34.62% over the past 12 months and -34.25% year-to-date.
In fiscal year 2025, VivoSim Labs, Inc. reported revenue of $144000.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, VivoSim Labs, Inc. (VIVS) stock price is $1.19. The stock is traded on NASDAQ under the ticker symbol VIVS. The 52-week range is $1.16 – $5.30.